DUAL PATHWAY INHIBITION USING LOW DOSE RIVAROXABAN PLUS LOW DOSE ASPIRIN IN PATIENTS WITH CARDIOVASCULAR DISEASE: A META-ANALYSIS

被引：0
|
作者：
Sibbing, Dirk [1 ]
Blaha, Michael J. [1 ]
Kishore, Amit [1 ]
Lanas, Angel [1 ]
Li, Li [1 ]
Santilli, Francesca [1 ]
Shi, Zhongwei [1 ]
Vardar, Burcu [1 ]
机构：
[1] Bayer AG, Berlin, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1134-002
引用
收藏
页码：1690 / 1690
页数：1
相关论文
共 50 条
  • [1] Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition
    Ramacciotti, Eduardo
    Weitz, Jeffrey I.
    [J]. THROMBOSIS RESEARCH, 2019, 184 : 44 - 49
  • [2] Low-dose aspirin in patients with stable cardiovascular disease: A meta-analysis
    Berger, Jeffrey S.
    Brown, David L.
    Becker, Richard C.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (01): : 43 - 49
  • [3] Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis
    Sibbing, Dirk
    Blaha, Michael J.
    Chawla, Rajinder
    Lavalle-Cobo, Augusto
    Kishore, Amit
    Lanas, Angel
    Li, Li
    Santilli, Francesca
    Schnell, Oliver
    Shi, Zhongwei
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [4] PHARMACODYNAMIC EFFECTS OF ADJUNCTIVE CLOPIDOGREL THERAPY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE ON DUAL PATHWAY INHIBITION WITH ASPIRIN AND LOW-DOSE RIVAROXABAN
    Franchi, Francesco
    Rollini, Fabiana
    Been, Latonya
    Abou Jaoude, Patrick
    Rivas, Andrea
    Zhou, Xuan
    Jia, Sida
    Maaliki, Naji
    Lee, Chang Hoon
    Maldonado, Andres Pineda
    Suryadevara, Siva
    Soffer, Daniel
    Zenni, Martin
    Jennings, Lisa
    Bass, Theodore
    Angiolillo, Dominick
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1187 - 1187
  • [5] COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE RIVAROXABAN PLUS ASPIRIN FOR THE PATIENTS WITH STABLE CARDIOVASCULAR DISEASE IN TAIWAN SETTING
    Lee, M. C.
    Liao, C. T.
    Toh, H. S.
    Sun, L.
    Chang, W. T.
    Su, H. C.
    [J]. VALUE IN HEALTH, 2019, 22 : S168 - S168
  • [6] Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive review
    Parascandolo, Eliot
    Eisen, Alon
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (09) : 577 - 585
  • [7] Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials
    Anand, Sonia S.
    Hiatt, Will
    Dyal, Leanne
    Bauersachs, Rupert
    Berkowitz, Scott D.
    Branch, Kelley R. H.
    Debus, Sebastian
    Fox, Keith A. A.
    Liang, Yan
    Muehlhofer, Eva
    Nehler, Mark
    Haskell, Lloyd P.
    Patel, Manesh
    Szarek, Michael
    Yusuf, Salim
    Eikelboom, John
    Bonaca, Marc P.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : E181 - E189
  • [8] Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
    Chen, Can
    Kan, Yuanqing
    Shi, Zhenyu
    Guo, Daqiao
    Fu, Weiguo
    Li, Yanli
    Lv, Qianzhou
    Li, Xiaoyu
    Si, Yi
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [9] Low-dose rivaroxaban plus aspirin for the prevention of cardiovascular events: an evaluation of COMPASS
    Bhagirath, Vinai C.
    Eikelboom, John W.
    Anand, Sonia S.
    [J]. FUTURE CARDIOLOGY, 2018, 14 (06) : 443 - 454
  • [10] LOW-DOSE ASPIRIN AND MORTALITY IN PATIENTS WITH CORONAVIRUS DISEASE 2019: A META-ANALYSIS
    Beran, Azizullah
    Mhanna, Mohammed
    Srour, Omar
    Ayesh, Hazem
    Khokher, Waleed
    Malhas, Saif-Eddin
    Abuhelwa, Ziad
    Alsaiqali, Mahmoud
    Eltahawy, Ehab Ahmed
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2060 - 2060
12345